EP2650007
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.6.2009EP published:
20.5.2015EP application number:
13002792.3
EPO information:
European Patent Register
Max expiry date:
1.6.2029
Title:
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases
Timeline
Today
2.6.2009EP application
20.5.2015EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
Bonny, ChristopheAddress:
Avenches, CH
Priority
Number:
PCT/EP2008/004341Date:
30.5.2008Country:
WO
Classification
Categories:
A61K 38/01, A61K 38/03, A61K 38/04, A61P 9/00, A61P 11/00, A61P 17/00, A61P 25/00, A61P 31/12, A61P 37/00